Quantcast

Latest Novo Nordisk Stories

2014-03-14 08:28:02

DUBLIN, Mar. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2msw4h/diabetes_herbal ) has announced the addition of the "Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Diabetes is a metabolic disorder arising mainly due to the fault in the...

2014-03-11 08:28:29

Patented technology could bring up to $167 million in milestone payments plus future long-term residual royalties to Caisson. OKLAHOMA CITY and AUSTIN, Texas, March 11, 2014 /PRNewswire/ -- Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, HEPtune(TM), announced today that it has expanded the scope of its partnership with global healthcare leader Novo Nordisk A/S (NYSE: NVO). This latest license agreement gives Novo Nordisk...

2014-03-10 12:26:21

New Jersey event brings hot-bed industry leaders to top-talent professionals ROOSEVELT, N.J., March 10, 2014 /PRNewswire/ -- HireLifeScience.com, the premier career networking website for the Life Science industries, will host its 5(th) annual career fair at The NJ Convention and Exposition Center at Raritan Center in Edison, NJ on September 30, 2014, sponsored by Novo Nordisk. This marks the first time that Novo Nordisk will present their open positions at the annual hiring...

2014-03-02 23:01:28

The foundation for the “Islamabad Call To Commitment and Action” was presented today at the concluding session of the Pakistan Diabetes Leadership Forum (PDLF). Islamabad, PK (PRWEB) March 02, 2014 The key points are the outcome of discussions and presentations by health practitioners and policy makers from Europe, Middle-East and Pakistan, who have over the past two days highlighted the alarming spread of diabetes in Pakistan and the urgency in improving diabetes care at both local...

2014-02-28 20:23:36

DUBLIN, February 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/xlfhdl/european) has announced the addition of the "Concise Analysis of the European Injectable Drug Delivery - Market Forecasts to 2017" [http://www.researchandmarkets.com/research/xlfhdl/european ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Injectable drug delivery technologies are a combination of two...

2014-02-27 08:30:30

DENVER, February 27, 2014 /PRNewswire/ -- Insulin Pens become smart with IOT "Internet of Things"! Vigilant(TM) unveils Bee+, the first smart insulin injection tracker. Bee+ combines technology and healthcare expertise to improve the lives of people affected by diabetes. A user-friendly electronic cap that fits most insulin pens in the market, Bee+ helps diabetics better manage their injections. Connected by Bluetooth Smart technology to compatible with Apple and...

2014-02-24 08:29:46

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the closing of a $49M Series B financing, led by Novo Ventures (a current Investor), with SV Life Sciences and Lundbeckfond Ventures joining Novartis Venture Fund in the syndicate. Thesan's mission is the development of novel approaches for the treatment of dermatological disorders, including acne and atopic dermatitis. "Our focus remains the development of new chemical entities with novel mechanisms of...

2014-02-12 12:31:53

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - Current and Future Players PharmaPoint: Type 2 Diabetes - Current and Future Players Summary GlobalData has released its pharma report, "PharmaPoint: Type 2 Diabetes - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Type 2 Diabetes Market. The report...

2014-02-11 08:32:31

LONDON, Feb. 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:China Insulin Delivery Devices Market Outlook and Trends Till 2018 Short DescriptionThis research report provides key market trends, market forecasts and competitive scenario of the insulin delivery devices in China through 2018.The product categories covered in this report include: -- Insulin Pens-- Insulin Syringes-- Insulin Pumps ScopeThe report highlights historic and forecasted...

2014-02-05 08:29:34

FREMONT, Calif., Feb. 5, 2014 /PRNewswire/ -- Zosano Pharma, Inc. (Zosano) announced today that it has entered into an agreement with Novo Nordisk A/S (NYSE: NVO) to develop a new transdermal presentation of semaglutide, an investigational proprietary human GLP-1 (Glucagon-Like Peptide-1) analogue, to be administered once weekly using Zosano's microneedle patch system for the treatment of type 2 diabetes. Initially, Zosano and Novo Nordisk will engage in collaborative efforts to...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'